Ram Aiyar
About Ram Aiyar
Ram Aiyar is the CEO and President with a Ph.D. and MBA, known for his extensive experience in biotech and pharma, including roles in finance, strategy, and product development.
Title: Chief Executive Officer & President
Ram Aiyar currently holds the position of Chief Executive Officer and President. He utilizes his extensive background in the biotech and pharma industries to lead and oversee company operations, strategic initiatives, and overall vision. His nearly two decades of experience in various roles, from finance to product development, underpin his leadership capabilities.
Education and Expertise
Ram Aiyar holds a M.S. and Ph.D. in electrical and computer engineering from Drexel University. Additionally, he earned an MBA in finance and business strategy from INSEAD, with coursework undertaken in both France and Singapore. His educational background provides a strong foundation in both technical and business disciplines, ensuring a comprehensive approach to executive management in the biotech and pharma sectors.
Biotech and Pharma Experience
Ram Aiyar brings nearly two decades of diverse experience in the biotech and pharmaceutical industries. He has been involved in all stages of development, from launch to clinical trials and commercialization. Throughout his career, he has held various leadership roles, including positions in finance, strategy, product development, and venture capital. His extensive knowledge and hands-on experience across multiple facets of the industry enable him to drive innovations and growth.
Entrepreneurial and Startup Leadership
Ram Aiyar has a distinguished history of launching and building biotech startups. As a co-founder, chief financial officer, and chief business officer at Corvidia Therapeutics, he played a critical role in leading the company to a successful acquisition by Novo Nordisk for $2.1 billion. His entrepreneurial spirit and strategic foresight have been instrumental in several startups, showcasing his ability to nurture and grow emerging companies.
Previous Positions and Roles
Ram Aiyar has held key roles in various organizations throughout his career. He was an entrepreneur-in-residence at BioHealth Innovation (BHI) and started his scientific career in research at Janssen Pharmaceuticals’ immunology group. Additionally, he has held leadership roles in corporate development, finance, and strategy at FlowMetric Inc., Sofinnova Partners, and J.P. Morgan Chase. These experiences have equipped him with a multidimensional understanding of the biotech and pharmaceutical industries.